Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Cellectis SA-ADR
Today
Create an eToro account to buy CLLS stock on a secure, user-friendly, multi-asset trading platform.
Buy Cellectis SA-ADR
Buy Cellectis SA-ADR
Cellectis SA-ADR CLLS
Buy CLLS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.
Stocks-CLLS-Cellectis SA-ADR

Cellectis SA-ADR CLLS

$1.470.01(0.68%)(1D)

CLLS Stock Price Chart

-6.37%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Cellectis SA-ADR share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Cellectis SA-ADR share price today is 1.47, reflecting a 0.68% change over the last 24 hours and -10.91% over the past week. The current market capitalization of CLLS is 108.86M with an average volume in the last three months of 132955.13. The stock has a P/E ratio of -1.47 and a dividend yield of 0%. With the stock’s beta sitting at 1.47
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$108.86M
Day’s Range
i
Shows the high and low prices of the day.
1.41 - 2.2
52W Range
i
Shows the high and low prices of the last year.
0.94 - 3.72
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
132955.13
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.47
Revenue
i
The total income generated by this company’s goods and services last year.
$29.07M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$1.51
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-1.03
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.47
What Is Cellectis SA-ADR?
Cellectis S.A. is a French clinical-stage biopharmaceutical company headquartered in Paris, with offices in New York City and Raleigh, North Carolina. Operating internationally, the firm develops treatments that harness the immune system via the use of proprietary gene editing technologies. The company's focus is on the development of therapies for use in treatments for cancer immunotherapy. Cellectis was established in 1999.

The firm is in the process of developing a unique allogeneic approach for CAR-T immunotherapies in oncology. It also provides life-saving UCART product candidates that aim to address unmet needs in patients suffering from various types of cancer, including acute myeloid leukaemia (AML), multiple myeloma (MM), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL).

The company’s technologies are primarily used in oncology research and pharmaceutical drug discovery programs, as well as in the areas of agronomics, bioproduction, and biotherapeutics. Cellectis has built on its expertise in combining meganucleases with engineered targeting DNA matrices into meganuclease recombination systems (MRS). These solutions are used for gene excision, correction, and replacement. The firm is publicly listed on the NASDAQ, where it trades under the ticker CLLS.

To keep track of Cellectis price movements, add CLLS stock to your eToro watchlist and start receiving real-time updates.
Buy CLLS

How can I buy Cellectis SA-ADR stocks?

To purchase Cellectis SA-ADR:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Cellectis SA-ADR (CLLS) page and place an order to buy Cellectis SA-ADR.
Buy CLLS
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Go to the Academy >
Graph
Buy Cellectis SA-ADR
Invest in Cellectis SA-ADR
Today
Create an eToro account to buy CLLS stock on a secure, user-friendly, multi-asset trading platform.
Buy CLLS

FAQ

The current price of CLLS is 1.47.
The average price target for Cellectis SA-ADR is 1.47. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Cellectis SA-ADR based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Cellectis SA-ADR is 108.86M
Daily Movers
Explore the biggest stocks movers on the market.
Buy CLLS
Scroll to top